279 related articles for article (PubMed ID: 25502757)
1. Role of LPA and the Hippo pathway on apoptosis in salivary gland epithelial cells.
Hwang SM; Jin M; Shin YH; Ki Choi S; Namkoong E; Kim M; Park MY; Park K
Exp Mol Med; 2014 Dec; 46(12):e125. PubMed ID: 25502757
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidic Acid Induces ECM Production via Activation of the Mechanosensitive YAP/TAZ Transcriptional Pathway in Trabecular Meshwork Cells.
Ho LTY; Skiba N; Ullmer C; Rao PV
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1969-1984. PubMed ID: 29677358
[TBL] [Abstract][Full Text] [Related]
3. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic Acid and IL-6 Trans-signaling Interact via YAP/TAZ and STAT3 Signaling Pathways in Human Trabecular Meshwork Cells.
Yemanyi F; Raghunathan V
Invest Ophthalmol Vis Sci; 2020 Nov; 61(13):29. PubMed ID: 33216119
[TBL] [Abstract][Full Text] [Related]
5. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.
Kim M; Kim T; Johnson RL; Lim DS
Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714
[TBL] [Abstract][Full Text] [Related]
7. Involvement of YAP, TAZ and HSP90 in contact guidance and intercellular junction formation in corneal epithelial cells.
Raghunathan VK; Dreier B; Morgan JT; Tuyen BC; Rose BW; Reilly CM; Russell P; Murphy CJ
PLoS One; 2014; 9(10):e109811. PubMed ID: 25290150
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
9. TAZ mediates lysophosphatidic acid-induced migration and proliferation of epithelial ovarian cancer cells.
Jeong GO; Shin SH; Seo EJ; Kwon YW; Heo SC; Kim KH; Yoon MS; Suh DS; Kim JH
Cell Physiol Biochem; 2013; 32(2):253-63. PubMed ID: 23942151
[TBL] [Abstract][Full Text] [Related]
10. Arsenic-induced cutaneous hyperplastic lesions are associated with the dysregulation of Yap, a Hippo signaling-related protein.
Li C; Srivastava RK; Elmets CA; Afaq F; Athar M
Biochem Biophys Res Commun; 2013 Sep; 438(4):607-12. PubMed ID: 23942117
[TBL] [Abstract][Full Text] [Related]
11. YAP/TAZ for cancer therapy: opportunities and challenges (review).
Guo L; Teng L
Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
[TBL] [Abstract][Full Text] [Related]
12. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H
Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125
[TBL] [Abstract][Full Text] [Related]
13. Arterial Wall Stress Induces Phenotypic Switching of Arterial Smooth Muscle Cells in Vascular Remodeling by Activating the YAP/TAZ Signaling Pathway.
Wang Y; Cao W; Cui J; Yu Y; Zhao Y; Shi J; Wu J; Xia Z; Yu B; Liu J
Cell Physiol Biochem; 2018; 51(2):842-853. PubMed ID: 30466081
[TBL] [Abstract][Full Text] [Related]
14. The novel YAP target gene, SGK1, upregulates TAZ activity by blocking GSK3β-mediated TAZ destabilization.
Yoo G; Kim T; Chung C; Hwang DS; Lim DS
Biochem Biophys Res Commun; 2017 Aug; 490(3):650-656. PubMed ID: 28634071
[TBL] [Abstract][Full Text] [Related]
15. Phospholipase Cϵ Activates Nuclear Factor-κB Signaling by Causing Cytoplasmic Localization of Ribosomal S6 Kinase and Facilitating Its Phosphorylation of Inhibitor κB in Colon Epithelial Cells.
Wakita M; Edamatsu H; Li M; Emi A; Kitazawa S; Kataoka T
J Biol Chem; 2016 Jun; 291(24):12586-12600. PubMed ID: 27053111
[TBL] [Abstract][Full Text] [Related]
16. Hypoxic conditions differentially regulate TAZ and YAP in cancer cells.
Yan L; Cai Q; Xu Y
Arch Biochem Biophys; 2014 Nov; 562():31-6. PubMed ID: 25078107
[TBL] [Abstract][Full Text] [Related]
17. TAZ and YAP are frequently activated oncoproteins in sarcomas.
Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR
Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148
[TBL] [Abstract][Full Text] [Related]
18. The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1.
Janse van Rensburg HJ; Azad T; Ling M; Hao Y; Snetsinger B; Khanal P; Minassian LM; Graham CH; Rauh MJ; Yang X
Cancer Res; 2018 Mar; 78(6):1457-1470. PubMed ID: 29339539
[TBL] [Abstract][Full Text] [Related]
19. Arhgef7 promotes activation of the Hippo pathway core kinase Lats.
Heidary Arash E; Song KM; Song S; Shiban A; Attisano L
EMBO J; 2014 Dec; 33(24):2997-3011. PubMed ID: 25425573
[TBL] [Abstract][Full Text] [Related]
20. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1.
Hansen CG; Ng YL; Lam WL; Plouffe SW; Guan KL
Cell Res; 2015 Dec; 25(12):1299-313. PubMed ID: 26611634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]